Key Highlights
- The Department of Energy has granted approval for the Documented Safety Analysis (DSA) of Oklo’s Groves Isotope Test Reactor located in Lockhart, Texas, marking the completion of all safety requirements prior to operations.
- The facility has now progressed to the DOE’s concluding pre-startup evaluation stage, with initial criticality scheduled for July 2026.
- The Groves facility represents the inaugural advanced nuclear reactor situated on private property to secure DSA authorization, utilizing entirely commercial fuel and components.
- Shares of OKLO climbed 5% during premarket hours following the announcement; the company maintains a $9.1 billion valuation despite experiencing a 27% decline in the last half-year.
- The Groves installation functions as an isotope production center rather than an energy plant — Oklo’s power generation goals depend on its Aurora powerhouse platform, which remains under development.
Oklo’s Groves Isotope Test Reactor facility situated in Lockhart, Texas has successfully navigated a significant regulatory checkpoint. On Wednesday, the U.S. Department of Energy granted authorization for the Documented Safety Analysis of the installation, advancing Oklo toward its inaugural reactor activation.
Shares of OKLO experienced a 5% surge in premarket activity following the development. The company presently carries a $9.1 billion valuation, despite registering a 27% decline across the previous six-month period.
The DSA represents the installation’s ultimate safety documentation requirement. Following this authorization, Groves transitions into the DOE’s concluding pre-startup assessment stage — a procedure encompassing a preparedness evaluation and activation clearance prior to introducing nuclear material and initiating test operations.
Oklo has established July 2026 as the target date for achieving first criticality at Groves. First criticality denotes the point when a reactor establishes a regulated, continuous nuclear fission sequence.
The schedule carries significance. Oklo was chosen during the previous year for a DOE program aimed at deploying a minimum of three experimental reactors at federal laboratories by Independence Day. The organization verified it remains aligned with that objective.
Chief Executive Jacob DeWitte characterized the development as a landmark achievement in an official statement, emphasizing that Groves represents “the first advanced reactor project to receive approval of its Documented Safety Analysis that is on privately owned land, with wholly commercially sourced fuel, equipment, and systems delivered by the private sector.”
The organization initiated construction on the Groves installation under twelve months ago. Development and operational activities have been managed by a private-sector team operating under DOE supervision.
Understanding the Groves Facility’s Purpose
Clarification regarding the Groves reactor’s function is important. This installation serves as an isotope manufacturing center, not an electricity generation plant. Power production is not part of its operational scope.
The facility’s mission involves producing radioisotopes utilized in cancer diagnostics and therapy, sophisticated manufacturing processes, scientific investigation, space missions, and defense applications. The United States presently relies substantially on international providers and outdated domestic installations for these critical materials.
Oklo’s electricity generation objectives center on its Aurora powerhouse concept, a fast fission reactor being developed at Idaho National Laboratory. A fuel production facility is simultaneously under construction at that location. The DOE has previously authorized the Preliminary Documented Safety Analysis for the Aurora initiative.
Additional Corporate Developments
Oklo has maintained operational momentum beyond the Groves project. The organization recently completed the acquisition of Creative Engineers, Inc., a company specializing in sodium and alkali-metal technology.
The company also executed a Letter of Intent with Centrus Energy Corp. for the procurement of high-assay low-enriched uranium (HALEU) designated for its Aurora powerhouse in Ohio, with shipments anticipated to commence in 2029.
Oklo and Standard Nuclear established a memorandum of understanding to investigate nuclear fuel reprocessing and advanced fuel production, concentrating on materials from a proposed installation in Oak Ridge, Tennessee.
Guggenheim launched coverage of Oklo with a neutral assessment, forecasting EBITDA profitability by 2030.
InvestingPro information indicates Oklo maintains a stronger cash position than debt obligations on its financial statements. The identical evaluation suggests the stock trades at a modest premium compared to its Fair Value calculation.
The subsequent formal milestone for Groves involves the DOE’s preparedness assessment and activation authorization before fuel introduction can advance.



